Detection of α-synuclein aggregates by fluorescence microscopy

Rejuvenation Research

Volumn 15, Issue 2, 2012, Pages 213-216

  Hubinger S ^a   Bannach, O ^a   Funke, S A ^b   Willbold, D ^a,b   Birkmann, E ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; BIOLOGICAL MARKER;

ARTICLE; CLINICAL FEATURE; DOPAMINERGIC NERVE CELL; FLUORESCENCE MICROSCOPY; HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN FOLDING;

ALPHA-SYNUCLEIN; BIOLOGICAL MARKERS; CIRCULAR DICHROISM; DOPAMINERGIC NEURONS; FLUORESCENT DYES; HUMANS; HYDROGEN-ION CONCENTRATION; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE; RECOMBINANT PROTEINS; SURFACE PROPERTIES; TEMPERATURE; THIAZOLES;

EID: 84860270658     PISSN: 15491684     EISSN: 15578577     Source Type: Journal    
DOI: 10.1089/rej.2011.1288     Document Type: Article

References (16)

1. Jankovic J. Parkinson's disease: Clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008;79:368-376
2. Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann NY Acad Sci 2003;991:1-14
3. Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, BraakE. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211
4. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997;388:839-840
5. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanowski JQ, Iwatsubo T. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 1998;152:879-884
6. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 1998;95:6469-6473
7. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaun RL. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047
8. Krüger R, Kuhn W, Müller T, Woitalla D, Graeber M, Kösel S, Przuntek H, Eppien JT, Schols L, Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease Nat Genet 1998;18:106-108
9. Zarranz JJ, Alegre J, Gómez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atares B, Llorens V, Gomez Tortosa E, de Sert T, Munoz DG, de Yebenes JG. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 2004;55:164-173
10. Hoyer W, Antony T, Cherny D, Heim G, Jovin TM, Subramaniam V. Dependence of alpha-synuclein aggregate morphology on solution conditions. J Mol Biol 2002;322: 383-393
11. LeVine H. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: Detection of amyloid aggregation in solution. Prot Sci 1993;2:404-410
12. Birkmann E, Henke F, Weinmann N, Dumpitak C, Groschup M, Funke A, Willbold D, Riesner D. Counting of single prion particles bound to a capture-antibody surface (surface- FIDA). Vet Microbiol 2007;123:294-304
13. ImageJ Software. Available at http://rsbweb.nih.gov/ij/
14. Janissen R, Oberbarnscheidt L, Oesterhelt F. Optimized straight forward procedure for covalent surface immobilization of different biomolecules for single molecule applications. Colloids Surf B Biointerfaces 2009;71: 200-207
15. Mollenhauer B, El-Agnaf OMA, Marcus K, Trenkwalder C, Schlossmacher MG. Quantification of a-synuclein in cerebrospinal fluid as a biomarker candidate: Review of the literature and considerations for future studies. Biomark Med 2010;4:683-699
16. Tokuda T, Qureshi MM, Ardah MT, Varghese S, Shehab SAS, Kasai T, Ishigami N, Tamaoka A, Nakagawa M, El-Agnaf OM. Detection of elevated levels of a-synuclein oligomers in CSF from patients with Parkinson disease. Neurology 2010;75:1766-1772